Medistim AsaOSL: MEDI

MEDI: Record revenue, margin expansion, and strategic hires set the stage for accelerated growth

· Issued by Medistim ASA

Record Q1 revenue and EBIT driven by strong product sales and robust growth across all regions, with significant margin expansion and a NOK 6 per share dividend approved. Strategic initiatives and new leadership appointments position the company for continued growth.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Medistim Asa

All Medistim Asa news releases